~~<i id='7BBD8793F3'><strike id='7BBD8793F3'><tt id='7BBD8793F3'><pre id='7BBD8793F3'></pre></tt></strike></i>~~

Home» Wikipedia» fashion

fashion

author：comprehensive 2025-09-29 08:09:43 Page View：1783

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Doctors push to include dialysis machines in emergency stockpile
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

explore

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Pennsylvania man bitten on the head by bear during attack in his garage

DANVILLE,Pa.--APennsylvaniamansayshe'spayingalotmoreattentiontohissurroundingsafterasurpriseatt

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

STAT series 'Denied by AI' wins major journalism prizes

MikeReddyforSTATDearReaders,PleasebearwithmeasIbragabouttwoofSTAT’smostaccomplished(andhumble)report